DE60226244D1 - Il-4 rezeptor sequenzvarianten, die mit typ i diabetes assoziiert sind - Google Patents
Il-4 rezeptor sequenzvarianten, die mit typ i diabetes assoziiert sindInfo
- Publication number
- DE60226244D1 DE60226244D1 DE60226244T DE60226244T DE60226244D1 DE 60226244 D1 DE60226244 D1 DE 60226244D1 DE 60226244 T DE60226244 T DE 60226244T DE 60226244 T DE60226244 T DE 60226244T DE 60226244 D1 DE60226244 D1 DE 60226244D1
- Authority
- DE
- Germany
- Prior art keywords
- diabetes
- type
- sequence variants
- receptor sequence
- variants associated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30691201P | 2001-07-20 | 2001-07-20 | |
| US306912P | 2001-07-20 | ||
| PCT/EP2002/007956 WO2003010335A2 (en) | 2001-07-20 | 2002-07-17 | Il-4 receptor sequence variation associated with type 1 diabetes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60226244D1 true DE60226244D1 (de) | 2008-06-05 |
| DE60226244T2 DE60226244T2 (de) | 2009-06-25 |
Family
ID=23187422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60226244T Expired - Lifetime DE60226244T2 (de) | 2001-07-20 | 2002-07-17 | Il-4 rezeptor sequenzvarianten, die mit typ i diabetes assoziiert sind |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20030152951A1 (de) |
| EP (1) | EP1412531B1 (de) |
| JP (1) | JP2004535822A (de) |
| AT (1) | ATE393238T1 (de) |
| CA (1) | CA2451394C (de) |
| DE (1) | DE60226244T2 (de) |
| WO (1) | WO2003010335A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7205106B1 (en) * | 2001-07-20 | 2007-04-17 | Roche Molecular Systems, Inc. | Association of polymorphisms in IL4-related genes with autoimmune disease |
| JPWO2006051886A1 (ja) * | 2004-11-12 | 2008-05-29 | 国立大学法人大阪大学 | 組織破壊によって機能障害を来たす自己免疫疾患の重症化の可能性を予測する方法 |
| EP2380994A1 (de) * | 2005-10-13 | 2011-10-26 | Hendrik Schulze-Koops | Mittel und Verfahren zur Vorhersage einer Gelenkzerstörung |
| GB0523276D0 (en) * | 2005-11-15 | 2005-12-21 | London Bridge Fertility | Chromosomal analysis by molecular karyotyping |
| AU2009246134B2 (en) | 2008-05-16 | 2016-03-03 | The Children's Hospital Of Philadelphia | Genetic alterations on chromosomes 21q, 6q and 15q and methods of use thereof for the diagnosis and treatment of type I diabetes |
-
2002
- 2002-07-03 US US10/189,956 patent/US20030152951A1/en not_active Abandoned
- 2002-07-17 CA CA002451394A patent/CA2451394C/en not_active Expired - Fee Related
- 2002-07-17 DE DE60226244T patent/DE60226244T2/de not_active Expired - Lifetime
- 2002-07-17 WO PCT/EP2002/007956 patent/WO2003010335A2/en active IP Right Grant
- 2002-07-17 JP JP2003515685A patent/JP2004535822A/ja active Pending
- 2002-07-17 AT AT02762370T patent/ATE393238T1/de not_active IP Right Cessation
- 2002-07-17 EP EP02762370A patent/EP1412531B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003010335A2 (en) | 2003-02-06 |
| JP2004535822A (ja) | 2004-12-02 |
| CA2451394A1 (en) | 2003-02-06 |
| EP1412531A2 (de) | 2004-04-28 |
| DE60226244T2 (de) | 2009-06-25 |
| WO2003010335A3 (en) | 2003-10-30 |
| US20030152951A1 (en) | 2003-08-14 |
| EP1412531B1 (de) | 2008-04-23 |
| ATE393238T1 (de) | 2008-05-15 |
| CA2451394C (en) | 2010-02-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY143215A (en) | Multifocal lenses for pre-presbyopic individuals | |
| IN2014DN05011A (de) | ||
| EP2236156A3 (de) | Verfahren zur Behandlung und Diagnose von Psoriasis | |
| HK1154940A1 (en) | Quality assays for antigen presenting cells | |
| CY1107339T1 (el) | Mu-1, μελος της οικογενειας υποδοχεα κυτοκινης | |
| EP1292678B8 (de) | G-protein gekoppelte rezeptoren | |
| WO2003066821A3 (en) | Molecules interacting with casl (mical) polynucleotides, polypeptides, and methods of using the same | |
| ATE393238T1 (de) | Il-4 rezeptor sequenzvarianten, die mit typ i diabetes assoziiert sind | |
| TR200003467T2 (tr) | Neisseria meningitidis antijenik polipeptidler, mütekabil polinükleotidler ve koruyucu antikorlar | |
| WO2002097060A3 (en) | Carbohydrate-associated proteins | |
| WO2000021986A3 (en) | Matrix-remodeling genes | |
| WO2004044165A3 (en) | Lipid-associated proteins | |
| WO2003063688A3 (en) | Protein modification and maintenance molecules | |
| WO2003076586A3 (en) | Nucleic acid-associated proteins | |
| WO2003054219A3 (en) | Nucleic acid-associated proteins | |
| DK1224222T3 (da) | Chemokinreceptor | |
| DE60127901D1 (de) | TCF-1 Nukleotidsequenzvariation | |
| WO2003038052A3 (en) | Nucleic acid-associated proteins | |
| WO2003100016A3 (en) | Protein modification and maintenance molecules | |
| ATE253223T1 (de) | Verfahren und materialien zur diagnose instabiler angina | |
| DE60329931D1 (de) | Fprl1-liganden und deren verwendung | |
| WO2002099115A3 (en) | Nucleic acid-associated proteins | |
| WO2003083084A3 (en) | Protein modification and maintenance molecules | |
| WO2002088322A3 (en) | Cell adhesion and extracellular matrix proteins | |
| WO2003006618A3 (en) | Nucleic acid-associated proteins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |